PTCH1 Gene Variants, mRNA Expression, and Bioinformatics Insights in Mexican Cutaneous Squamous Cell Carcinoma Patients
Author:
Zambrano-Román Marianela12ORCID, Padilla-Gutiérrez Jorge R.1ORCID, Valle Yeminia1ORCID, Muñoz-Valle José Francisco1ORCID, Guevara-Gutiérrez Elizabeth3, López-Olmos Patricia Aidé3, Sepúlveda-Loza Laura Cristina4, Bautista-Herrera Luis Alberto5, Valdés-Alvarado Emmanuel1ORCID
Affiliation:
1. Instituto de Investigación en Ciencias Biomédicas (IICB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico 2. Doctorado en Genética Humana, Departamento de Biología Molecular y Genómica, Universidad de Guadalajara, Guadalajara 44340, Mexico 3. Departamento de Dermatología, Instituto Dermatológico de Jalisco “Dr. José Barba Rubio”, Secretaría de Salud Jalisco, Zapopan 45190, Mexico 4. Departamento de Dermatología, Hospital Civil de Guadalajara “Fray Antonio Alcalde”, Guadalajara 44200, Mexico 5. Departamento de Farmacobiología, Centro Universitario de Ciencias Exactas e Ingenierías, Guadalajara 44430, Mexico
Abstract
Background: Skin cancer is one of the most frequent types of cancer, and cutaneous squamous cell carcinoma (cSCC) constitutes 20% of non-melanoma skin cancer (NMSC) cases. PTCH1, a tumor suppressor gene involved in the Sonic hedgehog signaling pathway, plays a crucial role in neoplastic processes. Methods: An analytical cross-sectional study, encompassing 211 cSCC patients and 290 individuals in a control group (CG), was performed. A subgroup of samples was considered for the relative expression analysis, and the results were obtained using quantitative real-time PCR (qPCR) with TaqMan® probes. The functional, splicing, and disease-causing effects of the proposed variants were explored via bioinformatics. Results: cSCC was predominant in men, especially in sun-exposed areas such as the head and neck. No statistically significant differences were found regarding the rs357564, rs2236405, rs2297086, and rs41313327 variants of PTCH1, or in the risk of cSCC, nor in the mRNA expression between the cSCC group and CG. A functional effect of rs357564 and a disease-causing relation to rs41313327 was identified. Conclusion: The proposed variants were not associated with cSCC risk in this Mexican population, but we recognize the need for analyzing larger population groups to elucidate the disease-causing role of rare variants.
Funder
University of Guadalajara
Reference65 articles.
1. Cives, M., Mannavola, F., Lospalluti, L., Sergi, M.C., Cazzato, G., Filoni, E., Cavallo, F., Giudice, G., Stucci, L.S., and Porta, C. (2020). Non-Melanoma Skin Cancers: Biological and Clinical Features. Int. J. Mol. Sci., 21. 2. Zavdy, O., Coreanu, T., Bar-On, D.Y., Ritter, A., Bachar, G., Shpitzer, T., Kurman, N., Mansour, M., Ad-El, D., and Rozovski, U. (2023). Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients—A Comparison between Different Immunomodulating Conditions. Cancers, 15. 3. Clinical and Genetic Factors Associated with Cutaneous Squamous Cell Carcinoma in Kidney and Heart Transplant Recipients;Sanders;Transplant. Direct,2015 4. Corchado-Cobos, R., García-Sancha, N., González-Sarmiento, R., Pérez-Losada, J., and Cañueto, J. (2020). Cutaneous Squamous Cell Carcinoma: From Biology to Therapy. Int. J. Mol. Sci., 21. 5. The Role of Drugs and Selected Dietary Factors in Cutaneous Squamous Cell Carcinogenesis;Damps;Postep. Dermatol. Alergol.,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|